Caliper Eyes Expansion into Companion Dx with New Platforms
January 13, 2011
Caliper Eyes Expansion into Companion Dx with New Platforms
With a new LabChip platform and tissue imaging capabilities, Caliper has its eye on expanding in molecular diagnostics and targeting companion diagnostic deals as its personalized medicine strategy evolves.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.
Related Stories
- Caliper Teams with Seegene on MDx
January 12, 2011 / GenomeWeb Daily News - Gen-Probe Expects Panther to Drive Growth for Several Years
January 11, 2011 / GenomeWeb Daily News - JP Morgan Healthcare Conference, Day Two: Life Technologies, Roche, Agilent, Thermo Fisher, Cepheid, GenMark
January 9, 2013 / GenomeWeb Daily News - Medco Taps MolecularMD to Provide BCR-ABL Testing for TKI Inhibitors in CML Patients
June 8, 2011 / Pharmacogenomics Reporter - Cepheid Recalls Xpert MRSA/SA Blood Culture Product Due to False Negative Results
July 8, 2010 / PCR Insider